In terms of market performance, Nektar Therapeutics had a somewhat regular. The highest value for the stock in the past year was $1.93 on 05/13/24, while the lowest value was $0.46 on 12/13/23.
52-week price history of NKTR Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Nektar Therapeutics’s current trading price is -44.50% away from its 52-week high, while its distance from the 52-week low is 135.16%. The stock’s price range for this period has remained between $0.46 and $1.93. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.06 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.42 million over the last three months.
Financial Performance and Market Capitalization
Nektar Therapeutics (NKTR) has experienced a quarterly decline of -13.71% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 197.37M and boasts a workforce of 137 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2650, with a change in price of -0.3500. Similarly, Nektar Therapeutics recorded 1,279,545 in trading volume during the last 100 days, posting a change of -24.65%.
NKTR Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NKTR stands at 4.22. Similarly, the long-term debt-to-equity ratio is also 3.78.
NKTR Stock Stochastic Average
As of today, the raw stochastic average of Nektar Therapeutics over the past 50 days is 17.76%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 18.48%. Additionally, the Stochastic %K and %D values for the company were 30.71% and 32.30%, respectively, over the past 20 days.
NKTR Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 89.38% this year. Over the last six months, there has been a stronger performance of -23.57%. The price of NKTR leaped by -13.01% during the last 30 days period. For the last 5-days stocks have slided -1.83%.
